Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
J Robot Surg ; 16(4): 951-956, 2022 Aug.
Article in English | MEDLINE | ID: mdl-34716876

ABSTRACT

The purpose is to report the United Kingdom's largest single-centre experience of robotically assisted laparoscopic radical prostatectomies (RALP), using the neurovascular structure-adjacent frozen-section (NeuroSAFE) technique. We describe the utilisation and outcomes of this technique. This is a retrospective study from 2012 to 2019 on 520 patients undergoing NeuroSAFE RALP at our Institution. Our Institution's database was analysed for false-positive frozen-section (FS) margins as confirmed on paraffin histopathological analysis: functional outcomes of potency, continence, and biochemical recurrence (BCR). The median (range) of console time was 145 (90-300) min. In our cohort, positive FS was seen in 30.7% (160/520) of patients, with a confirmatory paraffin analysis in 91.8% of our patients' cohort (147/160). The neurovascular bundles (NVBs) that underwent secondary resection contained tumour in 26.8% (43/160) of the cases. Biochemical recurrence (BCR) was 6.7% (35/520), of which FS was positive in 40% (14/35) of those cases. There were insufficient evidence of a statistical association of urinary incontinence and positive surgical margin rates according to NS or NVB resection. NeuroSAFE enables intraoperative confirmation of the oncologic safety of a NS procedure. Patients with a positive FS on NeuroSAFE can be converted to a negative surgical margin (NSM) by ipsilateral wide resection. This spared 1 in 4 men from positive margins posterolaterally in our series. Limitations are the absence of a matched contemporary cohort of NS RALP without NeuroSAFE in our centre.


Subject(s)
Laparoscopy , Robotic Surgical Procedures , Humans , Laparoscopy/methods , Male , Margins of Excision , Paraffin , Prostatectomy/methods , Retrospective Studies , Robotic Surgical Procedures/methods , Treatment Outcome , United Kingdom/epidemiology
3.
Clin Endocrinol (Oxf) ; 91(5): 624-632, 2019 11.
Article in English | MEDLINE | ID: mdl-31295360

ABSTRACT

OBJECTIVE: Testosterone replacement is generally considered likely to be required only at testicular radiation doses in excess of 20Gy. Long-term data are not available for patients receiving 9-14.4Gy as part of Total Body Irradiation in childhood. DESIGN: Retrospective cohort study. DATA COLLECTION: notes review, laboratory results, prescription of testosterone. PATIENTS: Forty-two of 96 boys who received Total Body Irradiation (9-14.4Gy) and Haematopoietic Stem Cell Transplantation for childhood leukaemia at Great Ormond Street Hospital between 1981-2011 and survived >5 years. MEASUREMENTS: The serum concentrations of testosterone and gonadotrophins and the prescription of testosterone were recorded. RESULTS: Of the 42 boys included, 37 (88%) entered puberty spontaneously and 5 required induction. Median length of follow-up was 19.4 years (range 5-33.1). At last follow-up, 23 of the 37 (62%) with spontaneous puberty were receiving testosterone replacement and 4 of the 5 (80%) with induced puberty. CONCLUSION: This study with the benefit of long follow-up indicates that Leydig cell failure occurs with radiation doses <20Gy. It may occur many years after irradiation and mandates long-term screening for hypogonadism.


Subject(s)
Gonadotrophs/metabolism , Testosterone/blood , Cells, Cultured , Hematopoietic Stem Cell Transplantation , Humans , Leydig Cells/drug effects , Leydig Cells/metabolism , Male , Retrospective Studies , Testis/cytology , Testis/drug effects , Testis/metabolism , Whole-Body Irradiation
SELECTION OF CITATIONS
SEARCH DETAIL